# Parmax Pharma Ltd (PARMAX)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹31.17
Day Change: -2.59%
52W High: ₹47.84
52W Low: ₹22.6
Market Cap: ₹12 Cr

## Valuation
P/E: 0
P/B: 0
EPS: ₹-13.55
Book Value: ₹0
Dividend Yield: 0%

## Returns
1Y Return: -33.44%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Parmax Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Parmax Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Extra Ordinary General Meeting Scheduled To Be Held On May 27, 2026
- Announcement: Announcement under Regulation 30 (LODR)-Change in Management
- BSE Filing: Extra Ordinary General Meeting Scheduled To Be Held On May 27, 2026

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-16T23:58:31.280Z
Price History Updated: 2026-05-19T01:03:01.950Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:03:01.950Z
Quant Updated: 2026-05-19T01:03:01.950Z
Sentiment Updated: 2026-05-19T01:03:01.950Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹18 Cr
Operating Profit: ₹1 Cr (OPM 5.67%)
Net Profit: ₹0 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2022: Rev ₹18Cr | PAT ₹0Cr | OPM 5.67%
FY 2023: Rev ₹15Cr | PAT ₹0Cr | OPM 5.21%
FY 2024: Rev ₹11Cr | PAT ₹-6Cr | OPM -42.07%

## Balance Sheet (FY 2022)
Total Assets: ₹18 Cr
Total Liabilities: ₹12 Cr
Borrowings: ₹5 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/parmax
Disclaimer: For research and education only. Not investment advice.